HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guiling Li Selected Research

pamiparib

4/2024Biomarker-driven targeted therapy in patients with recurrent platinum-resistant epithelial ovarian cancer (BRIGHT): protocol for an open-label, multicenter, umbrella study.
1/2022Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guiling Li Research Topics

Disease

41Neoplasms (Cancer)
05/2024 - 06/2009
19Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2024 - 09/2014
10Ovarian Neoplasms (Ovarian Cancer)
06/2024 - 05/2014
7Carcinoma (Carcinomatosis)
06/2024 - 06/2009
6Neoplasm Metastasis (Metastasis)
03/2022 - 06/2009
5Carcinogenesis
08/2023 - 05/2012
5COVID-19
12/2022 - 01/2021
4Ovarian Epithelial Carcinoma
06/2024 - 01/2021
4Liver Cirrhosis (Hepatic Cirrhosis)
12/2023 - 03/2021
4Disease Progression
01/2023 - 09/2017
4Infections
01/2023 - 10/2019
3Atherosclerosis
11/2022 - 01/2005
3Lymphatic Metastasis
01/2022 - 08/2015
3Hepatocellular Carcinoma (Hepatoma)
12/2021 - 01/2014
3Ataxia Telangiectasia (Louis Bar Syndrome)
12/2018 - 06/2015
2Hyperplasia
04/2024 - 02/2022
2Triple Negative Breast Neoplasms
07/2023 - 01/2023
2Virus Diseases (Viral Diseases)
01/2023 - 10/2019
2Body Weight (Weight, Body)
01/2023 - 01/2021
2Heterotopic Ossification (Ectopic Ossification)
11/2022 - 10/2022
2Hypertension (High Blood Pressure)
11/2022 - 01/2018
2Mitochondrial Diseases (Mitochondrial Disease)
11/2022 - 06/2007
2Chronic Disease (Chronic Diseases)
03/2022 - 02/2021
2Adenocarcinoma
01/2022 - 08/2015
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 01/2022
2Obesity
01/2021 - 03/2015
2Myocardial Ischemia (Ischemic Heart Diseases)
11/2019 - 05/2008
2Lung Neoplasms (Lung Cancer)
01/2019 - 01/2019
2Colonic Neoplasms (Colon Cancer)
09/2016 - 03/2012
2Colorectal Neoplasms (Colorectal Cancer)
07/2016 - 12/2014
2Pituitary Neoplasms (Pituitary Adenoma)
04/2013 - 05/2012
2Atopic Dermatitis (Atopic Eczema)
09/2012 - 01/2012
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
06/2024
1Stomach Neoplasms (Stomach Cancer)
05/2024

Drug/Important Bio-Agent (IBA)

10LipidsIBA
03/2024 - 04/2012
7PlatinumIBA
06/2024 - 01/2021
7Biomarkers (Surrogate Marker)IBA
05/2024 - 05/2012
7Proteins (Proteins, Gene)FDA Link
02/2022 - 05/2008
6Immune Checkpoint InhibitorsIBA
04/2024 - 08/2019
5Cisplatin (Platino)FDA LinkGeneric
03/2024 - 04/2017
5MicroRNAs (MicroRNA)IBA
01/2023 - 01/2014
5Liposomes (Liposome)IBA
04/2019 - 01/2012
5Messenger RNA (mRNA)IBA
01/2019 - 10/2007
4Poly(ADP-ribose) Polymerase InhibitorsIBA
05/2024 - 01/2021
4EnzymesIBA
11/2020 - 05/2008
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
05/2024 - 01/2023
3Bevacizumab (Avastin)FDA Link
04/2024 - 01/2022
3DNA (Deoxyribonucleic Acid)IBA
09/2023 - 03/2012
3Reactive Oxygen Species (Oxygen Radicals)IBA
09/2023 - 01/2014
3Immunoglobulin G (IgG)IBA
12/2022 - 04/2021
3benzamideIBA
10/2022 - 03/2021
3Cardiolipins (Cardiolipin)IBA
01/2021 - 03/2007
3CateninsIBA
09/2020 - 01/2019
3N-nitroso-N-methyltyramine (NNMT)IBA
07/2016 - 01/2014
3Nicotinamide N-MethyltransferaseIBA
07/2016 - 01/2014
2niraparibIBA
06/2024 - 01/2023
2130-nm albumin-bound paclitaxelIBA
04/2024 - 01/2023
2pamiparibIBA
04/2024 - 01/2022
2TitaniumIBA
04/2024 - 02/2022
2AntioxidantsIBA
03/2024 - 03/2022
2RNA (Ribonucleic Acid)IBA
03/2024 - 01/2023
2Photosensitizing Agents (Photosensitizers)IBA
09/2023 - 07/2023
2apatinibIBA
01/2023 - 01/2022
2SphingolipidsIBA
01/2023 - 10/2019
2AntibodiesIBA
12/2022 - 06/2022
2Immunoglobulin M (IgM)IBA
12/2022 - 04/2021
2B7-H1 AntigenIBA
12/2022 - 01/2019
2alpha-2-HS-GlycoproteinIBA
11/2022 - 10/2022
2Immunologic Factors (Immunomodulators)IBA
11/2022 - 10/2022
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2022 - 01/2020
2Therapeutic UsesIBA
01/2022 - 10/2007
2LigandsIBA
01/2022 - 01/2014
2Angiogenesis InhibitorsIBA
01/2022 - 01/2018
2Drug CarriersIBA
09/2021 - 03/2021
2Silicon Dioxide (Silica)FDA LinkGeneric
09/2021 - 03/2021
2CholesterolIBA
03/2021 - 01/2005
2Fatty Acids (Saturated Fatty Acids)IBA
01/2021 - 10/2019
2liposomal doxorubicin (Doxil)FDA Link
01/2021 - 04/2013
21-dodecylpyridoxal (PLD)IBA
01/2021 - 04/2019
2Glucose (Dextrose)FDA LinkGeneric
11/2020 - 05/2014
2Small Interfering RNA (siRNA)IBA
11/2020 - 01/2014
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
09/2020 - 09/2020
2Purinergic P2X3 ReceptorsIBA
11/2019 - 05/2008
2AcidsIBA
04/2019 - 10/2007
2Succinate Dehydrogenase (Fumarate Reductase)IBA
01/2019 - 01/2019
2Phosphotransferases (Kinase)IBA
04/2017 - 06/2009
2N(1)-methylnicotinamideIBA
07/2016 - 12/2014
2Hepatitis B Surface Antigens (HBsAg)FDA Link
09/2014 - 01/2014
2Caspase 3 (Caspase-3)IBA
01/2014 - 06/2009
2Tacrolimus (Prograf)FDA LinkGeneric
09/2012 - 01/2012
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2024

Therapy/Procedure

18Therapeutics
06/2024 - 10/2007
15Drug Therapy (Chemotherapy)
06/2024 - 06/2014
5Immunotherapy
04/2024 - 01/2019
4Radiotherapy
01/2020 - 06/2015
2Precision Medicine
04/2024 - 07/2023
2Photochemotherapy (Photodynamic Therapy)
09/2023 - 07/2023
2Radiofrequency Ablation
03/2022 - 12/2021
2Lymph Node Excision (Lymph Node Dissection)
09/2017 - 02/2015
2Hysterectomy
02/2015 - 06/2014